Better prognosis among long-term responders treated with Tolvaptan for cirrhosis

In decompensated liver cirrhosis, long-term responders with water retention treated with tolvaptan without recurrence experienced significantly better prognosis, according to study results.
“Our data also suggested that obtaining a long-term response without recurrence might be important for achieving a good prognosis,” Masato Nakai, MD, from the department of gastroenterology and hepatology at Hokkaido University Graduate School of Medicine in Japan, said. “In the treatment of decompensated cirrhosis with water retention, the addition of treatments that control inflammation,

Source link

WordPress database error: [Error writing file '/tmp/MYBq8IQp' (Errcode: 28 - No space left on device)]
SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (432986) AND ( wp_term_relationships.term_taxonomy_id IN (37) ) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY RAND() LIMIT 0, 3

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy